2005
DOI: 10.1053/j.jvca.2005.03.010
|View full text |Cite
|
Sign up to set email alerts
|

Effects of Ketamine on Serum and Tracheobronchial Aspirate Interleukin-6 Levels in Infants Undergoing Cardiac Surgery

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2007
2007
2019
2019

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 17 publications
(7 citation statements)
references
References 26 publications
0
7
0
Order By: Relevance
“…Nevertheless, at present, the studies conducted in a pediatric population failed to report any beneficial effect of ketamine on the postoperative inflammatory reaction [48][49][50].…”
Section: Anti-proinflammatory Effectmentioning
confidence: 85%
“…Nevertheless, at present, the studies conducted in a pediatric population failed to report any beneficial effect of ketamine on the postoperative inflammatory reaction [48][49][50].…”
Section: Anti-proinflammatory Effectmentioning
confidence: 85%
“…Another study conducted in a pediatric cardiac surgery population failed to demonstrate any anti‐inflammatory action of ketamine after ECC. The administration of steroids in both the control and the ketamine groups probably explains this negative result . In patients undergoing liver transplantation, ketamine administration was associated with reduced levels of circulating TNF‐α and IL‐6 .…”
Section: Ketamine As a “Regulator” Of The Inflammatory Reaction: Clinmentioning
confidence: 99%
“…Ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist, is commonly used in veterinary medicine, pediatric surgery, and neonatal intensive care for its anaesthetic and analgesic properties (Mellon et al 2007). Clinically, ketamine has been shown to be an anti-inflammatory agent acting by decreasing serum levels of interleukin 6 (IL-6) and tumour necrosis factor-alpha (TNFα) in patients undergoing cardiac surgeries and liver transplantation (Roytblat et al 1998;Zeyneloglu et al 2005;Yang et al 2006). In addition, in vitro studies have shown that lipopolysaccharide-activated macrophages ) and glial cells (Tanaka et al 2013) have decreased IL-6, TNFα, and IL-1β gene expression when treated with ketamine.…”
Section: Introductionmentioning
confidence: 99%